Bliss GVS Pharma Share Analysis: Revenue Growth Slow, Receivables High Aur Public Holding Badh Rahi Hai!

Date:

Share post:

Bliss GVS Pharma Share Analysis: Kya Share Me Chhupa Hai Koi Risk?

Pharma sector ki company Bliss GVS Pharma Ltd haal hi me investors ke beech charcha ka vishay bani hui hai. Ek taraf public holding lagatar badh rahi hai, jabki doosri taraf company ki revenue growth utni majboot nazar nahi aa rahi. Iske alawa, trade receivables bhi kaafi high level par pahunch gaye hain.

Aise me sawal uthta hai ki kya company ke fundamentals strong hain ya investors kuch important red flags ko ignore kar rahe hain?

Revenue Growth Abhi Bhi Slow

Sabse pehla concern company ki revenue growth ko lekar hai.

Kya Dikh Raha Hai?
Sales growth ki speed kaafi slow hai.
Business expansion expected level par nahi dikh raha.
Revenue me strong acceleration nazar nahi aa raha.
Pharma sector ke kai peers ke mukable growth relatively weak lagti hai.

Isliye investors ko sirf share price movement dekhkar decision nahi lena chahiye.

Trade Receivables Revenue Ke Lagbhag 54%

Yeh sabse bada red flag ho sakta hai.

Trade Receivables Ka Matlab

Trade receivables wo paisa hota hai jo company ne sales to kar di hai lekin payment abhi tak receive nahi hua.

Concern Kyu Hai?
Receivables revenue ke lagbhag 54% tak pahunch gaye hain.
High receivables future cash flow par pressure bana sakte hain.
Agar customers payment delay karte hain to working capital requirement badh sakti hai.
Cash conversion cycle weak ho sakti hai.

Isliye investors ko sales ke saath-saath cash collection par bhi dhyan dena chahiye.

Public Holding Lagatar Badh Rahi Hai

Ek aur interesting point company ke shareholding pattern me dekhne ko milta hai.

Positive Ya Negative?

Public holding ka badhna hamesha positive ya negative nahi hota.

Investors Ko Kya Dekhna Chahiye?
Kya institutional investors bhi buying kar rahe hain?
Kya promoters apni holding maintain kar rahe hain?
Public participation kisi strong business growth ke karan hai ya sirf market sentiment ki wajah se?

Agar public holding badh rahi ho aur fundamentals improve na ho rahe hon, to investors ko extra caution rakhna chahiye.

Company Ke Important Red Flags

Red Flags

✔ Revenue growth slow hai
✔ Receivables ka level high hai
✔ Cash conversion par nazar rakhna zaruri hai
✔ Public participation badh rahi hai lekin business growth limited hai
✔ Future quarters me execution important rahega

Kya Bliss GVS Pharma Me Investment Karna Chahiye?

Filhal company me kuch positive factors ke saath kuch important risks bhi maujood hain.

Ek taraf pharma sector ka long-term potential hai, lekin doosri taraf slow revenue growth aur high receivables investors ke liye warning sign ho sakte hain.

Isliye investment decision lene se pehle quarterly results, cash flow aur receivables trend ko closely monitor karna zaruri hai.

Bliss GVS Pharma ek aisi company hai jahan shareholding pattern investors ka dhyan khinch raha hai. Halaanki, revenue growth ki slow pace aur revenue ke mukable lagbhag 54% receivables kuch sawal khade karte hain.

Isliye sirf public buying ko dekhkar investment decision lena sahi nahi hoga. Sabse pehle company ke cash flow, receivable management aur future growth prospects ko evaluate karna zaruri hai.

📺 Bliss GVS Pharma Share Analysis ka detailed video analysis dekhne ke liye niche diye gaye YouTube link par click karein aur poori research samjhein.

🎥 Watch Full Analysis: Bliss GVS Pharma Share Analysis

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Texmaco Rail Share Analysis: Revenue Growth Slow, Debtor Days High Aur Cash Flow Par Pressure!

Texmaco Rail Share Analysis: Kya Company Me Chhupa Hai Koi Risk? Railway sector ke shares pichhle kuch saalon me...

Alivus Life Sciences Share Analysis: Slow Revenue Growth Aur Cash Flow Risk Ka Sach

Alivus Life Sciences Share Analysis Alivus Life Sciences ka share investors ke beech kaafi charcha me hai. Pehli nazar...

Indian Hume Pipe Share Analysis: Revenue Growth Nahi, Profit Other Income Se! Kya Yeh Red Flag Hai?

Indian Hume Pipe Ka Sach: Revenue Growth Nahi, Profit Kahan Se Aa Raha Hai? Indian Hume Pipe Company Ltd...

NIIT Ltd Share Analysis: Revenue ₹953 Crore Se Girkar ₹390 Crore, Fir Bhi Dividend! Kya Yeh Red Flag Hai?

NIIT Ltd ek samay Bharat ki leading education aur training companies me se ek mani jati thi. Lekin...
WhatsApp chat